Resistin administration or hyperresistinemia impairs glucose tolerance and induces hepatic insulin resistance [7,8], whereas mice deficient in resistin are protected from obesity-associated insulin resistance [9]. This evidence concerns the gene RETN and obesity due to melanocortin 4 receptor deficiency.